Because of the higher prevalence of BRCA2 and other pathogenic germline variants, routine referral for genetic counseling and testing (including BRCA1, BRCA2, PALB2, and others as appropriate) is strongly recommended for all men diagnosed with breast cancer [9,10]. This evidence concerns the gene BRCA2 and breast carcinoma.